Pfizer Now Expects To Submit Pediatric COVID-19 Vaccine Data By Early June
The AP (5/3) reports, “Pfizer now hopes to tell U.S. regulators how well its COVID-19 vaccine works in the littlest kids by late May or early June.” The company “is testing three extra-small doses of its vaccine in children under 5 after two shots didn’t prove quite strong enough.” The initial data “had been expected last month but the company laid out the latest timeline Tuesday during its discussion of quarterly financial results.”